Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS44017951
Basic Information
VIS ID
TVIS44017951
Fusion event
HTLV-1-GAN integration
Validated
No
Detection method
HTS
Data source
download(RID)
Sample type
Nontumor
Disease
HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Quality evaluation
Normal
Reported year
2017
PubMed ID
29186194
Virus Sequence
Virus name
HTLV-1
Reference genome
Not given
Host Sequence
Chromosome
chr16
Cytoband
q23.2
Reference genome
GRCh37/hg19
Start
81356030/81322425 (Hg38)
End
81356030/81322425 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA16D
Target gene
GAN
miRNAs that regulate target gene
hsa-mir-3662
;
hsa-mir-32-5p
;
hsa-mir-92a-3p
;
hsa-mir-92b-3p
;
hsa-mir-4781-3p
;
hsa-mir-4713-5p
;
hsa-mir-7977
;
hsa-mir-2116-3p
;
hsa-mir-532-3p
;
hsa-mir-150-5p
;
hsa-mir-4639-3p
;
hsa-mir-4457
;
hsa-mir-4731-3p
;
hsa-mir-4801
;
hsa-mir-124-3p
;
hsa-mir-340-5p
;
hsa-mir-3117-5p
;
hsa-mir-425-5p
;
hsa-mir-3163
;
hsa-mir-548c-3p
;
hsa-mir-186-3p
;
hsa-mir-6871-3p
;
hsa-mir-605-5p
;
hsa-mir-600
;
hsa-mir-4279
;
hsa-mir-6749-3p
;
hsa-mir-4469
;
hsa-mir-4740-3p
;
hsa-mir-4714-3p
;
hsa-mir-211-5p
;
hsa-mir-204-5p
;
hsa-mir-3156-3p
;
hsa-mir-188-3p
;
hsa-mir-4766-3p
;
hsa-mir-4685-3p
;
hsa-mir-4287
;
hsa-mir-4301
;
hsa-mir-3908
;
hsa-mir-4703-5p
;
hsa-mir-3942-5p
;
hsa-mir-599
;
hsa-mir-1260b
;
hsa-mir-1260a
;
hsa-mir-3145-3p
;
hsa-mir-7855-5p
;
hsa-mir-4710
;
hsa-mir-6829-3p
;
hsa-mir-4792
;
hsa-mir-6791-3p
;
hsa-mir-4299
;
hsa-mir-5193
;
hsa-mir-6891-3p
;
hsa-mir-6072
;
hsa-mir-582-3p
;
hsa-mir-6516-5p
;
hsa-mir-3678-3p
;
hsa-mir-1273h-3p
;
hsa-mir-2467-3p
;
hsa-mir-6844
;
hsa-mir-141-5p
;
hsa-mir-3157-5p
;
hsa-mir-5096
;
hsa-mir-3187-3p
;
hsa-mir-4435
;
hsa-mir-588
;
hsa-mir-4701-5p
;
hsa-mir-548s
;
hsa-mir-203b-3p
;
hsa-mir-7158-3p
;
hsa-mir-378a-5p
;
hsa-mir-197-3p
;
hsa-mir-193b-5p
;
hsa-mir-8086
;
hsa-mir-4755-3p
;
hsa-mir-6821-3p
;
hsa-mir-6790-3p
;
hsa-mir-4680-5p
;
hsa-mir-4635
;
hsa-mir-3653-5p
;
hsa-mir-4716-5p
;
hsa-mir-1207-5p
;
hsa-mir-1302
;
hsa-mir-1911-3p
;
hsa-mir-296-3p
;
hsa-mir-3122
;
hsa-mir-3153
;
hsa-mir-3179
;
hsa-mir-3616-3p
;
hsa-mir-3652
;
hsa-mir-3913-5p
;
hsa-mir-3914
;
hsa-mir-3928-3p
;
hsa-mir-3936
;
hsa-mir-4298
;
hsa-mir-4425
;
hsa-mir-4430
;
hsa-mir-4436b-3p
;
hsa-mir-4468
;
hsa-mir-4632-5p
;
hsa-mir-4668-5p
;
hsa-mir-4763-3p
;
hsa-mir-548ao-3p
;
hsa-mir-6077
;
hsa-mir-6081
;
hsa-mir-6721-5p
;
hsa-mir-6733-5p
;
hsa-mir-6735-5p
;
hsa-mir-6739-5p
;
hsa-mir-6756-5p
;
hsa-mir-6766-5p
;
hsa-mir-6847-5p
;
hsa-mir-6879-5p
;
hsa-mir-7-5p
;
hsa-mir-7843-5p
;
hsa-mir-92a-1-5p
;
hsa-mir-101-3p
;
hsa-mir-1262
;
hsa-mir-1273g-3p
;
hsa-mir-4252
;
hsa-mir-4701-3p
;
hsa-mir-4793-3p
;
hsa-mir-508-5p
;
hsa-mir-566
;
hsa-mir-582-5p
;
hsa-mir-6512-3p
;
hsa-mir-652-3p
;
hsa-mir-661
;
hsa-mir-6720-5p
;
hsa-mir-6736-5p
;
hsa-mir-6742-3p
;
hsa-mir-6776-5p
;
hsa-mir-6789-3p
;
hsa-mir-6849-3p
;
hsa-mir-766-3p
;
hsa-mir-7703
Nearest miRNA
hsa-mir-1225/Upstream/4453406; hsa-mir-11401/Downstream/62593;
Nearest TSS
ENST00000527434/Upstream/7473;
ENST00000567335/Downstream/42994;
Nearest CpG islands
None/Target,
chr16-CpG: 29/Upstream/6504
,
chr16-CpG: 25/Downstream/81174
Upstream sequence
TGCAGAGGAGATAAGACATCTCAGCAGCGGCTAGGTACTAGCAAGATGGTGGCAACCAACTGGCAAGGCCTTTGCCCTTCTGGAGCCTCCATTTCAATAG
Downstream sequence
AGTAAGGCTTAGAGGGCCAATGCGTATCATAAATGGAAGATAGGAGGACTAGTTTTTAAAAGTTGACTGTTGAATAATGAAATACAGACCAATTAAATAT
Reference
Furuta, R., et al.Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo. PLoS Pathog,2017,13(11): e1006722.
Sample Information
×
Sample name
HAM/TSP#1
Sample type
Nontumor
Gender
Female
CpG Island Information
×
Download
Curate